Clinical trials regulatory environment 'hostile' and 'oppressive' – cancer specialist

Ireland falling short of target of six per cent cancer patient involvement in trials, Oireachtas committee hears

Related Keywords

Ireland ,Colm Henry ,John Kennedy ,National Cancer Control Programme Prof Riste ,National Cancer Strategy ,Oireachtas Committee On Health ,Trinity St James ,Cancer Institute Prof John Kennedy ,Joint Oireachtas Committee ,Prof Kennedy ,North Atlantic ,Clinical Officer Dr Colm Henry ,